S.E.L.U.R.L. PHARMACIE FOURES : revenue, balance sheet and financial ratios

S.E.L.U.R.L. PHARMACIE FOURES is a French company founded 29 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in JEGUN (32360), this company of category PME shows in 2020 a revenue of 1.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - S.E.L.U.R.L. PHARMACIE FOURES (SIREN 411350499)
Indicator 2023 2020 2019 2018 2017
Revenue N/C 1 063 120 € 1 033 428 € 974 658 € 1 059 228 €
Net income 66 138 € 40 850 € 35 678 € 47 154 € 58 698 €
EBITDA N/C 48 070 € 43 392 € 49 938 € 58 795 €
Net margin N/C 3.8% 3.5% 4.8% 5.5%

Revenue and income statement

In 2023, S.E.L.U.R.L. PHARMACIE FOURES generates positive net income of 66 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2023: 59 k€ -> 66 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

66 138 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 18%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

18.425%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

65.083%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

39.1%

Solvency indicators evolution
S.E.L.U.R.L. PHARMACIE FOURES

Sector positioning

Debt ratio
18.43 2023
2019
2020
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Excellent

In 2023, the debt ratio of S.E.L.U.R.L. PHARMACIE FO... (18.43) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
65.08% 2023
2019
2020
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good

In 2023, the financial autonomy of S.E.L.U.R.L. PHARMACIE FO... (65.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
0.15 years 2020
2019
2020
Q1: 1.45 years
Med: 4.71 years
Q3: 9.29 years
Excellent

In 2020, the repayment capacity of S.E.L.U.R.L. PHARMACIE FO... (0.15) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 176.67. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

176.667

Liquidity indicators evolution
S.E.L.U.R.L. PHARMACIE FOURES

Sector positioning

Liquidity ratio
176.67 2023
2019
2020
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Average

In 2023, the liquidity ratio of S.E.L.U.R.L. PHARMACIE FO... (176.67) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
0.22x 2020
2019
2020
Q1: 0.68x
Med: 3.88x
Q3: 8.36x
Average

In 2020, the interest coverage of S.E.L.U.R.L. PHARMACIE FO... (0.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
S.E.L.U.R.L. PHARMACIE FOURES

Positioning of S.E.L.U.R.L. PHARMACIE FOURES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of S.E.L.U.R.L. PHARMACIE FOURES is estimated at 780 393 € (range 474 594€ - 1 097 058€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
474k€ 780k€ 1097k€
780 393 € Range: 474 594€ - 1 097 058€
NAF 5 année 2023

Valuation method used

Net Income Multiple
66 138 € × 11.8x = 780 394 €
Range: 474 595€ - 1 097 058€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare S.E.L.U.R.L. PHARMACIE FOURES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about S.E.L.U.R.L. PHARMACIE FOURES

What is the revenue of S.E.L.U.R.L. PHARMACIE FOURES ?

The revenue of S.E.L.U.R.L. PHARMACIE FOURES in 2020 is 1.1 M€.

Is S.E.L.U.R.L. PHARMACIE FOURES profitable?

Yes, S.E.L.U.R.L. PHARMACIE FOURES generated a net profit of 66 k€ in 2023.

Where is the headquarters of S.E.L.U.R.L. PHARMACIE FOURES ?

The headquarters of S.E.L.U.R.L. PHARMACIE FOURES is located in JEGUN (32360), in the department Gers.

Where to find the tax return of S.E.L.U.R.L. PHARMACIE FOURES ?

The tax return of S.E.L.U.R.L. PHARMACIE FOURES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does S.E.L.U.R.L. PHARMACIE FOURES operate?

S.E.L.U.R.L. PHARMACIE FOURES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.